Cargando…

Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics

BACKGROUND: Foot-and-mouth disease (FMD) is the most economically important and highly contagious disease of cloven-hoofed animals worldwide. Control of the disease has been mainly based on large-scale vaccinations with whole-virus inactivated vaccines. In recent years, a series of outbreaks of type...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Pinghua, Bai, Xingwen, Sun, Pu, Li, Dong, Lu, Zengjun, Cao, Yimei, Fu, Yuanfang, Bao, Huifang, Chen, Yingli, Xie, Baoxia, Liu, Zaixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488552/
https://www.ncbi.nlm.nih.gov/pubmed/22591597
http://dx.doi.org/10.1186/1746-6148-8-57
_version_ 1782248636557557760
author Li, Pinghua
Bai, Xingwen
Sun, Pu
Li, Dong
Lu, Zengjun
Cao, Yimei
Fu, Yuanfang
Bao, Huifang
Chen, Yingli
Xie, Baoxia
Liu, Zaixin
author_facet Li, Pinghua
Bai, Xingwen
Sun, Pu
Li, Dong
Lu, Zengjun
Cao, Yimei
Fu, Yuanfang
Bao, Huifang
Chen, Yingli
Xie, Baoxia
Liu, Zaixin
author_sort Li, Pinghua
collection PubMed
description BACKGROUND: Foot-and-mouth disease (FMD) is the most economically important and highly contagious disease of cloven-hoofed animals worldwide. Control of the disease has been mainly based on large-scale vaccinations with whole-virus inactivated vaccines. In recent years, a series of outbreaks of type O FMD occurred in China (including Chinese Taipei, Chinese Hong Kong) posed a tremendous threat to Chinese animal husbandry. Its causative agent, type O FMDV, has evolved into three topotypes (East–South Asia (ME-SA), Southeast Asia (SEA), Cathay (CHY)) in these regions, which represents an important obstacle to disease control. The available FMD vaccine in China shows generally good protection against ME-SA and SEA topotype viruses infection, but affords insufficient protection against some variants of the CHY topotype. Therefore, the choice of a new vaccine strain is of fundamental importance. RESULTS: The present study describes the generation of a full-length infectious cDNA clone of FMDV vaccine strain and a genetically modified virus with some amino acid substitutions in antigenic sites 1, 3, and 4, based on the established infectious clone. The recombinant viruses had similar growth properties to the wild O/HN/CHA/93 virus. All swine immunized with inactivated vaccine prepared from the O/HN/CHA/93 were fully protected from challenge with the viruses of ME-SA and SEA topotypes and partially protected against challenge with the virus of CHY topotype at 28 days post-immunization. In contrast, the swine inoculated with the genetically modified vaccine were completely protected from the infection of viruses of the three topotypes. CONCLUSIONS: Some amino acid substitutions in the FMDV vaccine strain genome did not have an effect on the ability of viral replication in vitro. The vaccine prepared from genetically modified FMDV by reverse genetics significantly improved the protective efficacy to the variant of the CHY topotype, compared with the wild O/HN/CHA/93 virus. Thus, the full-length cDNA clone of FMDV can be a useful tool to develop genetically engineered FMDV vaccine candidates to help control porcinophilic FMD epidemics in China.
format Online
Article
Text
id pubmed-3488552
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34885522012-11-05 Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics Li, Pinghua Bai, Xingwen Sun, Pu Li, Dong Lu, Zengjun Cao, Yimei Fu, Yuanfang Bao, Huifang Chen, Yingli Xie, Baoxia Liu, Zaixin BMC Vet Res Research Article BACKGROUND: Foot-and-mouth disease (FMD) is the most economically important and highly contagious disease of cloven-hoofed animals worldwide. Control of the disease has been mainly based on large-scale vaccinations with whole-virus inactivated vaccines. In recent years, a series of outbreaks of type O FMD occurred in China (including Chinese Taipei, Chinese Hong Kong) posed a tremendous threat to Chinese animal husbandry. Its causative agent, type O FMDV, has evolved into three topotypes (East–South Asia (ME-SA), Southeast Asia (SEA), Cathay (CHY)) in these regions, which represents an important obstacle to disease control. The available FMD vaccine in China shows generally good protection against ME-SA and SEA topotype viruses infection, but affords insufficient protection against some variants of the CHY topotype. Therefore, the choice of a new vaccine strain is of fundamental importance. RESULTS: The present study describes the generation of a full-length infectious cDNA clone of FMDV vaccine strain and a genetically modified virus with some amino acid substitutions in antigenic sites 1, 3, and 4, based on the established infectious clone. The recombinant viruses had similar growth properties to the wild O/HN/CHA/93 virus. All swine immunized with inactivated vaccine prepared from the O/HN/CHA/93 were fully protected from challenge with the viruses of ME-SA and SEA topotypes and partially protected against challenge with the virus of CHY topotype at 28 days post-immunization. In contrast, the swine inoculated with the genetically modified vaccine were completely protected from the infection of viruses of the three topotypes. CONCLUSIONS: Some amino acid substitutions in the FMDV vaccine strain genome did not have an effect on the ability of viral replication in vitro. The vaccine prepared from genetically modified FMDV by reverse genetics significantly improved the protective efficacy to the variant of the CHY topotype, compared with the wild O/HN/CHA/93 virus. Thus, the full-length cDNA clone of FMDV can be a useful tool to develop genetically engineered FMDV vaccine candidates to help control porcinophilic FMD epidemics in China. BioMed Central 2012-05-16 /pmc/articles/PMC3488552/ /pubmed/22591597 http://dx.doi.org/10.1186/1746-6148-8-57 Text en Copyright ©2012 Li et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Li, Pinghua
Bai, Xingwen
Sun, Pu
Li, Dong
Lu, Zengjun
Cao, Yimei
Fu, Yuanfang
Bao, Huifang
Chen, Yingli
Xie, Baoxia
Liu, Zaixin
Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics
title Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics
title_full Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics
title_fullStr Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics
title_full_unstemmed Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics
title_short Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics
title_sort evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488552/
https://www.ncbi.nlm.nih.gov/pubmed/22591597
http://dx.doi.org/10.1186/1746-6148-8-57
work_keys_str_mv AT lipinghua evaluationofageneticallymodifiedfootandmouthdiseasevirusvaccinecandidategeneratedbyreversegenetics
AT baixingwen evaluationofageneticallymodifiedfootandmouthdiseasevirusvaccinecandidategeneratedbyreversegenetics
AT sunpu evaluationofageneticallymodifiedfootandmouthdiseasevirusvaccinecandidategeneratedbyreversegenetics
AT lidong evaluationofageneticallymodifiedfootandmouthdiseasevirusvaccinecandidategeneratedbyreversegenetics
AT luzengjun evaluationofageneticallymodifiedfootandmouthdiseasevirusvaccinecandidategeneratedbyreversegenetics
AT caoyimei evaluationofageneticallymodifiedfootandmouthdiseasevirusvaccinecandidategeneratedbyreversegenetics
AT fuyuanfang evaluationofageneticallymodifiedfootandmouthdiseasevirusvaccinecandidategeneratedbyreversegenetics
AT baohuifang evaluationofageneticallymodifiedfootandmouthdiseasevirusvaccinecandidategeneratedbyreversegenetics
AT chenyingli evaluationofageneticallymodifiedfootandmouthdiseasevirusvaccinecandidategeneratedbyreversegenetics
AT xiebaoxia evaluationofageneticallymodifiedfootandmouthdiseasevirusvaccinecandidategeneratedbyreversegenetics
AT liuzaixin evaluationofageneticallymodifiedfootandmouthdiseasevirusvaccinecandidategeneratedbyreversegenetics